HFMA ANI 2022 RCM Panel (2)

Everyone is talking and reading about the challenges associated with clinical denials. We all know something needs to be done about it—but how to best address these challenges is where the fuzziness comes into play. 

In this session, Aspirion joins healthcare revenue cycle executives from Banner Health, Phoenix Children’s Hospital, and the University of Miami UHealth in a candid discussion on the enterprise-wide clinical denial management practices each system is employing to prevent and recover lost revenue. Learn the strategies that bring improved revenue cycle performance into focus as well as lessons learned along the way from this panel of leading revenue cycle executives.

Learning objectives: 

  • Examine the elements of an effective enterprise-wide denial management approach 
  • Identify best practices for clinical denials tracking and measuring including DRG downgrades, clinical validations, and charge audits to glean financial      impacts
  • Illustrate front-end denial prevention practices to curtail denials downgrades and charge audits 

CPEs: 1.0 

Program Level: Overview  

Field of Study: Specialized Knowledge 

Prerequisite: None


View HFMA Annual Agenda